Literature DB >> 20348445

Reduced seed region-based off-target activity with lentivirus-mediated RNAi.

Richard A Klinghoffer1, Jill Magnus, Janell Schelter, Michele Mehaffey, Casey Coleman, Michele A Cleary.   

Abstract

Along with silencing intended target genes, transfected siRNAs regulate numerous unintended transcripts through a mechanism in which the equivalent of a microRNA-like seed region in the siRNA recognizes complementary sequences in transcript 3' UTRs. Amelioration of this off-target silencing would lead to more accurate interpretation of RNA interference (RNAi) experiments and thus greatly enhance their value. We tested whether lentivirus-mediated delivery of shRNA is prone to the sequence-based off-target activity prevalent in siRNA experiments. We compared target gene silencing and overall impact on global gene expression caused by multiple sequences delivered as both transfected siRNAs and lentivirus vector-expressed shRNAs. At equivalent levels of target gene silencing, signatures induced by shRNAs were significantly smaller than those induced by cognate siRNAs and arose less frequently from seed region activity. Interestingly, the low level of seed region-based off-target activity exhibited by shRNAs resulted in down-regulation of transcripts that were largely distinct from those regulated by siRNAs. On the basis of these observations, we recommend lentivirus-mediated RNAi for pathway profiling experiments that measure whole genome transcriptional readouts as well as for large-scale screens when resources for extensive follow up are limited.

Mesh:

Substances:

Year:  2010        PMID: 20348445      PMCID: PMC2856882          DOI: 10.1261/rna.1977810

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  17 in total

1.  Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation.

Authors:  Eric C Lai
Journal:  Nat Genet       Date:  2002-03-18       Impact factor: 38.330

2.  Expression profiling reveals off-target gene regulation by RNAi.

Authors:  Aimee L Jackson; Steven R Bartz; Janell Schelter; Sumire V Kobayashi; Julja Burchard; Mao Mao; Bin Li; Guy Cavet; Peter S Linsley
Journal:  Nat Biotechnol       Date:  2003-05-18       Impact factor: 54.908

3.  Synthetic shRNAs as potent RNAi triggers.

Authors:  Despina Siolas; Cara Lerner; Julja Burchard; Wei Ge; Peter S Linsley; Patrick J Paddison; Gregory J Hannon; Michele A Cleary
Journal:  Nat Biotechnol       Date:  2004-12-26       Impact factor: 54.908

4.  Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing.

Authors:  Aimee L Jackson; Julja Burchard; Devin Leake; Angela Reynolds; Janell Schelter; Jie Guo; Jason M Johnson; Lee Lim; Jon Karpilow; Kim Nichols; William Marshall; Anastasia Khvorova; Peter S Linsley
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

5.  Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity.

Authors:  Aimee L Jackson; Julja Burchard; Janell Schelter; B Nelson Chau; Michele Cleary; Lee Lim; Peter S Linsley
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

6.  Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy.

Authors:  Dong-Ho Kim; Mark A Behlke; Scott D Rose; Mi-Sook Chang; Sangdun Choi; John J Rossi
Journal:  Nat Biotechnol       Date:  2004-12-26       Impact factor: 54.908

7.  3' UTR seed matches, but not overall identity, are associated with RNAi off-targets.

Authors:  Amanda Birmingham; Emily M Anderson; Angela Reynolds; Diane Ilsley-Tyree; Devin Leake; Yuriy Fedorov; Scott Baskerville; Elena Maksimova; Kathryn Robinson; Jon Karpilow; William S Marshall; Anastasia Khvorova
Journal:  Nat Methods       Date:  2006-03       Impact factor: 28.547

Review 8.  Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development.

Authors:  D D Rao; N Senzer; M A Cleary; J Nemunaitis
Journal:  Cancer Gene Ther       Date:  2009-08-28       Impact factor: 5.987

9.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

10.  siRNA-mediated off-target gene silencing triggered by a 7 nt complementation.

Authors:  Xiaoyu Lin; Xiaoan Ruan; Mark G Anderson; Jeffrey A McDowell; Paul E Kroeger; Stephen W Fesik; Yu Shen
Journal:  Nucleic Acids Res       Date:  2005-08-09       Impact factor: 16.971

View more
  11 in total

Review 1.  Personalized cancer approach: using RNA interference technology.

Authors:  John Nemunaitis; Donald D Rao; Shi-He Liu; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 2.  The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma?

Authors:  Benjamin Purow
Journal:  J Neurooncol       Date:  2010-11-17       Impact factor: 4.130

3.  Assessment of the Abundance and Potential Function of Human Papillomavirus Type 16 Circular E7 RNA.

Authors:  Richard C Wang; Eunice E Lee; Jiawei Zhao; Jiwoong Kim
Journal:  mBio       Date:  2022-05-17       Impact factor: 7.786

4.  Expression of Tyrosine Hydroxylase is Negatively Regulated Via Prion Protein.

Authors:  Marcio Henrique Mello da Luz; Isaias Glezer; Andre Machado Xavier; Marcelo Alberti Paiva da Silva; Jessica Monteiro Volejnik Pino; Thiago Panaro Zamith; Taynara Fernanda Vieira; Bruno Brito Antonio; Hanna Karen Moreira Antunes; Vilma Regina Martins; Kil Sun Lee
Journal:  Neurochem Res       Date:  2016-03-15       Impact factor: 3.996

5.  Human Argonaute 2 Is Tethered to Ribosomal RNA through MicroRNA Interactions.

Authors:  Blake L Atwood; Jessica L Woolnough; Gaelle M Lefevre; Mariana Saint Just Ribeiro; Gary Felsenfeld; Keith E Giles
Journal:  J Biol Chem       Date:  2016-06-10       Impact factor: 5.157

6.  Inhibition of B lymphocyte-induced maturation protein-1 reduces the production of autoantibody and alleviates symptoms of systemic lupus erythematosus.

Authors:  Jie Luo; Xiaochang Niu; Mingxu Zhang; Kejun Zhang; Ming Chen; Shaoli Deng
Journal:  Autoimmunity       Date:  2014-10-27       Impact factor: 2.815

Review 7.  RNAi mechanisms in Huntington's disease therapy: siRNA versus shRNA.

Authors:  Sebastian Aguiar; Bram van der Gaag; Francesco Albert Bosco Cortese
Journal:  Transl Neurodegener       Date:  2017-11-27       Impact factor: 8.014

8.  Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS.

Authors:  Tommaso Iannitti; Joseph M Scarrott; Shibi Likhite; Ian R P Coldicott; Katherine E Lewis; Paul R Heath; Adrian Higginbottom; Monika A Myszczynska; Marta Milo; Guillaume M Hautbergue; Kathrin Meyer; Brian K Kaspar; Laura Ferraiuolo; Pamela J Shaw; Mimoun Azzouz
Journal:  Mol Ther Nucleic Acids       Date:  2018-05-03       Impact factor: 8.886

Review 9.  Current prospects for RNA interference-based therapies.

Authors:  Beverly L Davidson; Paul B McCray
Journal:  Nat Rev Genet       Date:  2011-05       Impact factor: 53.242

10.  Short hairpin RNA-mediated gene silencing of ADAM17 inhibits the growth of breast cancer MCF‑7 cells in vitro and in vivo and its mechanism of action.

Authors:  Baoshan Hu; Xiangchao Meng; Yan Zhang; Mohammad Monir Hossain; Lijun Wu; Yuanyuan Zhang; Xiaobing Peng; Xuepeng Zhang
Journal:  Oncol Rep       Date:  2018-01-26       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.